Delivery Order SPE2DB20D3101-SPE2DB24FRNC9

Award Date 6/18/24
Potential Completion Date 6/20/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $5,423.70 for the supply of YUVAFEM 10 MCG VAGINAL INSERT 18S medical products. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 3, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,087.68 firm fixed-price delivery order is for the supply of YUVAFEM 10 MCG vaginal inserts. The contract has an ultimate completion date of August 30, 2024 and was awarded on August 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S medical products to the Defense Logistics Agency (DLA). The $1,084.23 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 23, 2024 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of YUVAFEM 10 MCG vaginal inserts. The contract has a firm fixed price of $1,986.47 and a period of performance through January 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a comprehensive range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The award is for $1,688.52 to supply YUVAFEM 10 MCG VAGINAL INSERT 8S, a pharmaceutical product. The contract has a firm fixed-price payment structure and an ultimate completion date of October 15, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds several significant...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of YUVAFEM 10 MCG vaginal inserts. The contract has a ceiling value of $9,511.73 and a period of performance through March 13, 2024. This delivery order contract is issued under a larger, single award indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,676.93, is for the delivery of YUVAFEM 10 MCG vaginal inserts. The contract has an ultimate completion date of January 13, 2025 and is a firm fixed price delivery order. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $2,219.78, is a firm fixed-price delivery order contract with a ceiling value of $2,219.78 and an ultimate completion date of May 3, 2024. The contract is not designated as a set-aside. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies...
This federal contract award is a delivery order with a firm fixed price of $1,250.43 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is for the supply of YUVAFEM 10 MCG vaginal inserts and has an ultimate completion date of March 11, 2025. The contract is not designated with a set-aside requirement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,438.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YUVAFEM 10 MCG vaginal inserts and has an ultimate completion date of October 11, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRNC9
    Delivery Order

This federal contract award is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S pharmaceutical products to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp's Corporate Office Division. The single-award Indefinite Delivery Contract (IDC) is valued up to $999,999,999.00 and runs through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. The contract does not have a set-aside designation. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/17/24, 10:23 AM